nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Clinic-based Survey of Clinical Characteristics and Practice Pattern of Dry Eye in Japan
|
Kawashima, Motoko |
|
2017 |
34 |
3 |
p. 732-743 |
artikel |
2 |
Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled Trial
|
Griffiths, Alison |
|
2017 |
34 |
3 |
p. 753-764 |
artikel |
3 |
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
|
Johnston, Robert L. |
|
2017 |
34 |
3 |
p. 703-712 |
artikel |
4 |
Behavior Modification: A Patient and Physician’s Perspective
|
Swanson, Elizabeth |
|
2017 |
34 |
3 |
p. 765-769 |
artikel |
5 |
Chronic Wound Healing: A Review of Current Management and Treatments
|
Han, George |
|
2017 |
34 |
3 |
p. 599-610 |
artikel |
6 |
Comment on “Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate”
|
Ravasio, Roberto |
|
2017 |
34 |
3 |
p. 770 |
artikel |
7 |
Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide
|
De Caterina, Raffaele |
|
2017 |
34 |
3 |
p. 620-637 |
artikel |
8 |
Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing Study
|
Martinez, Luc |
|
2017 |
34 |
3 |
p. 674-685 |
artikel |
9 |
Effectiveness of Calcifediol in Improving Muscle Function in Post-Menopausal Women: A Prospective Cohort Study
|
Iolascon, Giovanni |
|
2017 |
34 |
3 |
p. 744-752 |
artikel |
10 |
Erratum to: Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management
|
Singh, Dave |
|
2017 |
34 |
3 |
p. 771 |
artikel |
11 |
Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population
|
Nguyen, Hiep |
|
2017 |
34 |
3 |
p. 658-673 |
artikel |
12 |
Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study
|
Takeuchi, Tsutomu |
|
2017 |
34 |
3 |
p. 686-702 |
artikel |
13 |
Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report
|
Rey, Enrique |
|
2017 |
34 |
3 |
p. 587-598 |
artikel |
14 |
The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis
|
Danyliv, Andriy |
|
2017 |
34 |
3 |
p. 611-619 |
artikel |
15 |
The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder
|
Mandelli, Laura |
|
2017 |
34 |
3 |
p. 713-724 |
artikel |
16 |
The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On Therapy
|
Meece, Jerry |
|
2017 |
34 |
3 |
p. 638-657 |
artikel |
17 |
When People with Opioid-Induced Constipation Speak: A Patient Survey
|
Epstein, Robert S. |
|
2017 |
34 |
3 |
p. 725-731 |
artikel |